-Troy Sheffield (CEO and Founder of Co-E1)
Co-E1′s business mission is to market safe, reliable, effective products, which will improve the quality of life for all people. Co-E1 represents a quantum leap forward in our continued quest to develop the highest quality nutritional supplement products.
We recognize the need of proving our products are both safe and effective through sound, quantifiable, scientific principles and clinical research studies…not marketing hype. We have invested millions of dollars in research to achieve Investigative New Drug (IND) status for NADH, enabling us to conduct clinical trials. These clinical studies follow strict Pharmaceutical and Drug testing methodology consisting of double blind crossover, placebo controlled human studies. These studies have been conducted at prestigious medical institutions such as Georgetown University Medical Center.